EPO and type 2 diabetes mellitus: While intermittent hypoxia has, therefore, the potential to improve oxygen-carrying capacity in patients with type 2 diabetes, the reduced hemoglobin mass of this population may be due to low levels of erythropoietin, functional erythropoietin deficiency, and/or erythropoietin resistance in this population [4].